Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
Joseph R. Kallini, Ahmed Gabr, Riad Salem, et al.
Advances in Therapy (2016) Vol. 33, Iss. 5, pp. 699-714
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Recent progress in treatment of hepatocellular carcinoma.
Zhiqian Chen, Hao Xie, Mingming Hu, et al.
PubMed (2020) Vol. 10, Iss. 9, pp. 2993-3036
Closed Access | Times Cited: 262
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
Valerie Chew, Yun Hua Lee, Lu Pan, et al.
Gut (2018) Vol. 68, Iss. 2, pp. 335-346
Open Access | Times Cited: 190
Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
Clifford Akateh, Sylvester M. Black, Lanla Conteh, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 28, pp. 3704-3721
Open Access | Times Cited: 132
Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
Konstantinos Katsanos, Panagiotis Kitrou, Stavros Spiliοpoulos, et al.
PLoS ONE (2017) Vol. 12, Iss. 9, pp. e0184597-e0184597
Open Access | Times Cited: 120
Automated CT and MRI Liver Segmentation and Biometry Using a Generalized Convolutional Neural Network
Kang Wang, Adrija Mamidipalli, Tara Retson, et al.
Radiology Artificial Intelligence (2019) Vol. 1, Iss. 2, pp. 180022-180022
Open Access | Times Cited: 111
Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: A meta-analysis and systematic review
Chai Hong Rim, Chul Yong Kim, Dae Sik Yang, et al.
Radiotherapy and Oncology (2017) Vol. 129, Iss. 1, pp. 112-122
Open Access | Times Cited: 104
Loco-regional treatment of HCC: current status
Laura Crocetti, Irene Bargellini, Roberto Cioni
Clinical Radiology (2017) Vol. 72, Iss. 8, pp. 626-635
Closed Access | Times Cited: 92
Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options
Andreas Koulouris, Christos Tsagkaris, V. Spyrou, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 387-401
Open Access | Times Cited: 90
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 20, pp. 2416-2429
Open Access | Times Cited: 80
Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
Pedro Viveiros, Ahsun Riaz, Robert J. Lewandowski, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1085-1085
Open Access | Times Cited: 77
Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances
Khaled Y. Mahmoud, Shady A. Swidan, Mohamed A. El-Nabarawi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 66
Embolization therapy with microspheres for the treatment of liver cancer: State-of-the-art of clinical translation
Alexandre Pérez-López, Cristina Martín‐Sabroso, Laura Gómez-Lázaro, et al.
Acta Biomaterialia (2022) Vol. 149, pp. 1-15
Open Access | Times Cited: 58
Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma
Ahmed Gabr, Nadine Abouchaleh, Rehan Ali, et al.
Journal of Vascular and Interventional Radiology (2018) Vol. 29, Iss. 11, pp. 1502-1510.e1
Closed Access | Times Cited: 79
Folic acid conjugated polymeric drug delivery vehicle for targeted cancer detection in hepatocellular carcinoma
Nischal Koirala, Dola Das, Ehsan Fayazzadeh, et al.
Journal of Biomedical Materials Research Part A (2019) Vol. 107, Iss. 11, pp. 2522-2535
Closed Access | Times Cited: 56
Radiomics Features Extracted From Pre- and Postprocedural Imaging in Early Prediction of Treatment Response in Patients Undergoing Transarterial Radioembolization of Hepatic Lesions: A Systematic Review, Meta-Analysis, and Quality Appraisal Study
Mohammad Mirza‐Aghazadeh‐Attari, Tara Srinivas, Arun Kamireddy, et al.
Journal of the American College of Radiology (2024) Vol. 21, Iss. 5, pp. 740-751
Closed Access | Times Cited: 6
Radioembolization for the treatment of hepatocellular carcinoma
Hyo‐Cheol Kim
Clinical and Molecular Hepatology (2017) Vol. 23, Iss. 2, pp. 109-114
Open Access | Times Cited: 59
Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres
Christelle Bouvry, Xavier Palard, Julien Edeline, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-14
Open Access | Times Cited: 55
Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres
Eric A. Wang, Jeff Stein, Ross J. Bellavia, et al.
International Journal of Clinical Practice (2017) Vol. 71, Iss. 11, pp. e12972-e12972
Open Access | Times Cited: 50
MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy: A Comprehensive Review
Mishal Mendiratta‐Lala, William R. Masch, Kimberly L. Shampain, et al.
Radiology Imaging Cancer (2020) Vol. 2, Iss. 1, pp. e190024-e190024
Open Access | Times Cited: 44
Medicinal inorganic chemistry: an updated review on the status of metallodrugs and prominent metallodrug candidates
Victor M. Miranda
Reviews in Inorganic Chemistry (2021) Vol. 42, Iss. 1, pp. 29-52
Closed Access | Times Cited: 34
Safety and Efficacy of166Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study
Margot T.M. Reinders, Karel J. van Erpecum, Maarten L. J. Smits, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 12, pp. 1891-1898
Open Access | Times Cited: 28
Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization
Ahmed Gabr, Nadine Abouchaleh, Rehan Ali, et al.
European Journal of Radiology (2017) Vol. 93, pp. 100-106
Closed Access | Times Cited: 45
Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma
Guorong Jia, Juno Van Valkenburgh, Austin Z. Chen, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 14, Iss. 2
Open Access | Times Cited: 31
Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
Kylie E Zane, Paul Nagib, Sajid Jalil, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 5, pp. 885-895
Open Access | Times Cited: 20
Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study
Hyo‐Cheol Kim, Gyoung Min Kim
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top